Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Helen Perry is a pioneering endocrine surgeon whose research focuses on minimally invasive adrenal surgery, particularly for pheochromocytoma—a rare adrenal tumor. Her landmark 2024 international multicenter study, cited 12 times, systematically compared robotic and laparoscopic adrenalectomy outcomes, establishing critical safety and efficacy benchmarks for these advanced techniques. In a complementary 2024 analysis (7 citations), Dr. Perry addressed the challenging intersection of obesity and pheochromocytoma surgery, demonstrating that patients with elevated BMI can safely undergo adrenalectomy with careful perioperative management. Her work has been instrumental in refining surgical protocols and expanding access to minimally invasive procedures for complex patient populations. Dr. Perry’s research is characterized by rigorous multicenter collaboration and a commitment to translating operative innovations into improved clinical outcomes. Her contributions are shaping best practices in adrenal surgery and providing evidence-based guidance for surgeons worldwide, making her a leading voice in the field of endocrine surgical oncology.